APA

van Eijk R. P. A., Nikolakopoulos S., Roes K. C. B., Middelkoop B. M., Ferguson T. A., Shaw P. J., Leigh P. N., Al-Chalabi A., Eijkemans M. J. C. & van den Berg L. H. (20200611). Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials. : Journal of neurology, neurosurgery, and psychiatry.

Chicago

van Eijk Ruben P A, Nikolakopoulos Stavros, Roes Kit C B, Middelkoop Bas M, Ferguson Toby A, Shaw Pamela J, Leigh P Nigel, Al-Chalabi Ammar, Eijkemans Marinus J C and van den Berg Leonard H. 20200611. Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials. : Journal of neurology, neurosurgery, and psychiatry.

Harvard

van Eijk R. P. A., Nikolakopoulos S., Roes K. C. B., Middelkoop B. M., Ferguson T. A., Shaw P. J., Leigh P. N., Al-Chalabi A., Eijkemans M. J. C. and van den Berg L. H. (20200611). Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials. : Journal of neurology, neurosurgery, and psychiatry.

MLA

van Eijk Ruben P A, Nikolakopoulos Stavros, Roes Kit C B, Middelkoop Bas M, Ferguson Toby A, Shaw Pamela J, Leigh P Nigel, Al-Chalabi Ammar, Eijkemans Marinus J C and van den Berg Leonard H. Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials. : Journal of neurology, neurosurgery, and psychiatry. 20200611.